Back
Macrogenics Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
66
MGNX
Macrogenics
Last Price:
16.69
Seasonality Move:
32.01%
Sell
18
FDMT
4D Molecular Therapeutics
Last Price:
26.77
Seasonality Move:
-20.25%
Buy
66
Macrogenics (MGNX)
is a Buy
Is Macrogenics a Buy, Sell or Hold?
- The current Macrogenics [MGNX] share price is $16.94. The Score for MGNX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- MGNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $26.21. The Score for FDMT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MGNX Stock Price Chart
What is Macrogenics's stock price today?
-
The Macrogenics share price today is $16.94
The current trend is moderately bearish and MGNX is experiencing slight selling pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $26.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
MGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 51.93 | Buy |
| Chaikin Money Flow: | -396612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.5 - 17.72) | Buy |
| Bollinger Bands (100): | (9.56 - 17.46) | Buy |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 39.49 | Sell |
| Chaikin Money Flow: | -375821 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.35 - 32.81) | Sell |
| Bollinger Bands (100): | (16.42 - 29.7) | Buy |
MGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.97 | Sell |
| 20-day SMA: | 15.98 | Buy |
| 50-day SMA: | 17.01 | Sell |
| 200-day SMA: | 9.33 | Buy |
| 8-day EMA: | 17.33 | Sell |
| 20-day EMA: | 16.76 | Buy |
| 50-day EMA: | 15.92 | Buy |
| 200-day EMA: | 11.19 | Buy |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.41 | Sell |
| 20-day SMA: | 30.23 | Sell |
| 50-day SMA: | 29.01 | Sell |
| 200-day SMA: | 18.9 | Buy |
| 8-day EMA: | 27.52 | Sell |
| 20-day EMA: | 28.77 | Sell |
| 50-day EMA: | 27.59 | Sell |
| 200-day EMA: | 21.2 | Buy |
Macrogenics Earnings Growth & MGNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.90 per share, and an increase next year of $1.65 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Macrogenics Technical Analysis
| Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||